Fintech SPAC AIB Acquisition Seeks To Raise US$75 Million In IPO

Special purpose acquisition company AIB Acquisition Corporation (Nasdaq: AIBBU) went public on the Nasdaq Global Market today. The firm is looking to raise US$75.0 million through its initial public offering.

The offering consists of 7.5 million units priced at US$10.00 per unit. Each unit is composed of one Class A common share and one right to receive 1/10 of a common share upon the completion of business combination.

The company units trade on the Nasdaq big board under the symbol “AIBBU”. Once the securities separate, the company shares and rights will trade under the ticker symbols “AIB” and “AIBBR”, respectively.

The offering, expected to close on January 21, 2022, is being managed by Maxim Group as the sole bookrunner. The company has granted the underwriter a 45-day over-allotment option to purchase additional 1.125 million company units at the same IPO price.

The blank-check company intends to focus on businesses in the fintech industry. The firm is backed by American International Bank whose CEO Eric Chen also leads the SPAC as the chief executive officer.


Information for this briefing was found via Edgar the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Euro Sun: Rovina Copper-Gold Project Secures Some Major Funding

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

Agritech Firm AgriFORCE Seeks To Raise US$13.6 Million In Its IPO

Agriculture-focused technology company AgriFORCE Growing Systems Ltd. goes public today on the Nasdaq Capital Market....

Thursday, July 8, 2021, 10:21:00 AM

Biopharmaceutical Firm DICE Therapeutics Prices Upsized US$204 Million IPO

Biopharmaceutical company DICE Therapeutics, Inc. (Nasdaq: DICE) started publicly trading on the Nasdaq Global Market...

Thursday, September 16, 2021, 11:08:00 AM

Viral Diseases Tester Virax Biolabs Prices Upsized US$6.75 Million IPO

Biopharmaceutical company Virax Biolabs Group Limited recently increased its initial public offering size as it...

Wednesday, June 22, 2022, 02:14:00 PM

Tiger Williams-Led SPAC Williams Rowland Acquisition Seeks To Raise US$200 Million In IPO

Special purpose acquisition company Williams Rowland Acquisition Corp. (NYSE: WRACU) went public on the New...

Tuesday, July 27, 2021, 12:21:00 PM

Multi-Billion Dollar Metals SPAC Deal Collapses Amidst Turbulent Negotiations

ACG Acquisition Co’s $1 billion metals deal, initially promising as it included a prominent global...

Friday, September 29, 2023, 12:18:00 PM